Lv1
48 积分 2025-09-11 加入
Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancer
6个月前
已完结
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trial
6个月前
已完结
Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: A phase III-study from the German CONKO-study group
6个月前
已完结
A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer
6个月前
已完结
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial
6个月前
已完结
皖公网安备34019202002308
